1 completed, 1 enrolling by invitation. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
Follow PAH: new trials by email Literature Review of PAH trials Research Report on PAH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Ralinepag - PAH, Pulmonary Hypertension | Phase 3 | Enrolling by invitation | United Therapeutics | 1000 | 2019-09-23 | 2026-10-06 |
| A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Ralinepag, Placebo - PAH, Pulmonary Hypertension | Phase 3 | Completed | United Therapeutics | 687 | 2019-01-24 | 2026-06-16 |
Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Familial Primary Pulmonary Hypertension (2) · Hypertension (2) · Hypertension, Pulmonary (2) · Lung Diseases (2) · Pulmonary Arterial Hypertension (2) · Respiratory Tract Diseases (2) · Vascular Diseases (2)
Skin and Connective Tissue Diseases (2)
ralinepag (2)
Argentina (2) · Australia (2) · Austria (2) · Belgium (2) · Brazil (2) · Bulgaria (2) · Canada (2) · Chile (2) · China (2) · Croatia (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Greece (2)